Florescence | Clinical Research & Emerging Therapies

Clinical Research & Emerging Therapies

Where Discovery Begins to Bloom

A thoughtful exploration of clinical research, emerging neurological therapies, and innovations in rehabilitation. Discover what scientists are investigating, what the evidence tells us, and the questions that remain.

Explore Florescence

Clinical Trials in Focus

Accessible, evidence-based profiles of studies investigating neurological recovery, including spinal cord stimulation after stroke, myoelectric technology, deep brain stimulation, BreEStim, and the Johns Hopkins PHATHOM study. A study's inclusion does not imply it is recruiting or that its intervention is effective.

Emerging Science

Exploring neuromodulation, vagus nerve stimulation paired with rehabilitation, neuroplasticity, neural stem cell research, and assistive neurotechnology—with careful attention to evidence and limitations.

Research Explained

Understand study phases, eligibility, recruitment status, research outcomes, and how to distinguish promising early findings from established treatments.

The Founder’s Research Journal

Personal perspectives on the questions, discoveries, and conversations that can arise while following neurological research.

The Inspiration Behind Florescence

My interest in clinical research began shortly after my stroke in 2022 and deepened during six months of intensive rehabilitation in Türkiye. What started as independent research gradually led to conversations with investigators, including Professor Thierry Deltombe in Belgium, whom I first contacted about unpublished clinical trial results. That initial exchange developed into an ongoing professional relationship.

Four years into my recovery, restoring movement in my left arm and hand remains a significant challenge. With treatment now focused primarily on managing spasticity and maintaining comfort, I continue exploring emerging therapies, particularly neuromodulation and vagus nerve stimulation.

Florescence grew from this curiosity and firsthand experience. My goal is to make neurological research more accessible, highlight promising developments, and encourage informed exploration of treatments that may shape the future of rehabilitation—while remaining grounded in scientific evidence.

Florescence is an educational editorial initiative, not medical advice or a clinical trial enrollment service. Research and recruitment status can change. Discuss treatment and trial decisions with qualified healthcare professionals.